Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Martinez-Salamanca, JI; Shariat, SF; Rodriguez, JC; Chromecki, TF; Ficarra, V; Fritsche, HM; Kassouf, W; Matsumoto, K; Cabello, LO; Seitz, C; Tritschler, S; Walton, TJ; Zattoni, F; Novara, G.
Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study.
BJU Int. 2012; 109(8):1155-1161
Doi: 10.1111/j.1464-410X.2011.10479.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Chromecki Thomas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- OBJECTIVE To evaluate the prognostic role of ECOG Performance status (ECOG-PS) in a large multi-institutional international cohort of patients treated with radical nephroureterectomy for upper tract urothelial carcinoma. MATERIALS AND METHODS Data of 427 patients treated with radical nephroureterectomy at five international institutions in Asia, Europe and Northern America were collected retrospectively from 1987 to 2008. Logistic and Cox regression models were used for univariable and multivariable analyses. RESULTS ECOG-PS was 0 in 272 of 427 (64%) patients. The median follow-up of the whole cohort was 32 months. The five-year recurrence-free (RFS), cancer-specific (CSS) and overall (OS) survival estimates were 71.7%, 74.9% and 68.5%, respectively, in patients with ECOG-PS 0 compared with 60.1%, 67.8%, and 51.4% respectively, in patients with ECOG-PS >= 1 (P value 0.08 for RFS, 0.43 for CSS, and <0.001 for OS, respectively). On multivariable Cox regression analyses, ECOG-PS was not an independent predictor of either RFS (hazard ratio 1.4; P = 0.107) or CSS (hazard ratio 1.2; P = 0.426) but was an independent predictor of OS (hazard ratio 1.5; P = 0.03). CONCLUSIONS In this large multicentre international study, ECOG-PS was not significantly associated with RFS and CSS. Conversely we find a strong association with survival 1-month after surgery and OS. Further research is needed to ascertain the additive prognostic role of ECOG-PS in well-designed prospective multicentre studies.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Aged - epidemiology
- Carcinoma, Transitional Cell - diagnosis Carcinoma, Transitional Cell - mortality Carcinoma, Transitional Cell - surgery
- Carcinoma, Transitional Cell - epidemiology
- Female -
- Follow-Up Studies -
- Humans -
- Male -
- Middle Aged -
- Neoplasm Staging -
- Neoplasm Staging - epidemiology
- Prognosis -
- Retrospective Studies -
- Survival Rate - trends
- Treatment Outcome -
- Urologic Neoplasms - diagnosis Urologic Neoplasms - mortality Urologic Neoplasms - surgery
- Urologic Surgical Procedures -
- Find related publications in this database (Keywords)
- performance status
- ECOG
- prognosis
- urinary tract cancer
- urothelial carcinoma
- nephroureterectomy
- recurrence-free survival
- cancer-specific mortality